nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.02.2023 | Original Article

Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome

verfasst von: W. Vena, F. Carrone, A. Delbarba, O. Akpojiyovbi, L. C. Pezzaioli, P. Facondo, C. Cappelli, L. Leonardi, L. Balzarini, D. Farina, A. Pizzocaro, A. G. Lania, G. Mazziotti, A. Ferlin

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Klinefelter syndrome (KS) frequently causes skeletal fragility characterized by profound alterations in bone microstructure with increased risk of fractures. Increased body fat mass associated with decreased body lean mass are frequent features of KS with possible detrimental effects on skeletal health. In this cross-sectional study, we evaluated the associations between body composition parameters, vertebral fractures (VFs) and trabecular bone score (TBS) in adult subjects with KS.

Methods

Seventy-one adult males (median age 41 years, range 18–64) with 47, XXY KS were consecutively enrolled by two Endocrinology and Andrology Units (IRCCS Humanitas Research Hospital in Milan and ASST Spedali Civili in Brescia). Dual-energy X-ray absorptiometry (DXA) was performed to assess bone mineral density (BMD) at lumbar spine, femoral neck and total hip, TBS and body composition. Prevalence of VFs was assessed by quantitative morphometry on lateral spine X-rays.

Results

VFs were detected in 14 patients (19.7%), without significant association with low BMD (p = 0.912). In univariate logistic regression analysis, VFs were significantly associated with truncal/leg fat ratio (OR 2.32 per tertile; 95% CI 1.05–5.15; p = 0.038), whereas impaired TBS (detected in 23.4% of subjects) was associated with older age at study entry (p = 0.001) and at diagnosis of disease (p = 0.015), body mass index (BMI; p = 0.001), waist circumference (p = 0.007), fat mass index (FMI; p < 0.001), FMI/lean mass index (LMI) ratio (p = 0.001). Prevalence of VFs was not significantly different between subjects with impaired TBS as compared to those with normal TBS (26.7 vs. 18.4%; p = 0.485). Skeletal end-points were not significantly associated with duration of testosterone replacement therapy and serum testosterone and 25hydroxyvitamin D values.

Conclusion

Body composition might influence bone quality and risk of VFs in subjects with KS.

Zitzmann M, Aksglaede L, Corona G, Isidori AM, Juul A, T’Sjoen G et al (2021) European academy of andrology guidelines on Klinefelter Syndrome Endorsing Organization: European Society of Endocrinology. Andrology 9(1):145–167CrossRef

Kanakis GA, Nieschlag E (2018) Klinefelter syndrome: more than hypogonadism. Metab Clin Exp 86:135–144CrossRef

Bonomi M, Rochira V, Pasquali D, Balercia G, Jannini EA, Ferlin A (2017) Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism. J Endocrinol Invest 40(2):123–134CrossRef

Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA (2005) Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab 90(12):6516–6522CrossRef

Bojesen A, Juul S, Birkebaek N, Gravholt CH (2004) Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab 89(8):3830–3834CrossRef

Vena W, Pizzocaro A, Indirli R, Amer M, Maffezzoni F, Delbarba A et al (2020) Prevalence and determinants of radiological vertebral fractures in patients with Klinefelter syndrome. Andrology 8(6):1699–1704CrossRef

Porcelli T, Maffezzoni F, Pezzaioli LC, Delbarba A, Cappelli C, Ferlin A (2020) Management of endocrine disease: male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis? Eur J Endocrinol 183(3):R75-r93CrossRef

Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39(4):440–488CrossRef

Shanbhogue VV, Hansen S, Jørgensen NR, Brixen K, Gravholt CH (2014) Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in Klinefelter syndrome. J Bone Miner Res 29(11):2474–2482CrossRef

10.

Piot A, Plotton I, Boutroy S, Bacchetta J, Ailloud S, Lejeune H et al (2022) Klinefelter bone microarchitecture evolution with testosterone replacement therapy. Calcif Tissue Int 111(1):35–46CrossRef

11.

Tahani N, Nieddu L, Prossomariti G, Spaziani M, Granato S, Carlomagno F et al (2018) Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome. Endocrine 61(2):327–335CrossRef

12.

Pedersini R, Amoroso V, Maffezzoni F, Gallo F, Turla A, Monteverdi S et al (2019) Association of fat body mass with vertebral fractures in postmenopausal women with early breast cancer undergoing adjuvant aromatase inhibitor therapy. JAMA Netw Open 2(9):e1911080CrossRef

13.

de Araújo IM, Parreiras ESLT, Carvalho AL, Elias J Jr, Salmon CEG, de Paula FJA (2020) Insulin resistance negatively affects bone quality not quantity: the relationship between bone and adipose tissue. Osteoporos Int 31(6):1125–1133CrossRef

14.

Ma WY, Yang CY, Shih SR, Hsieh HJ, Hung CS, Chiu FC et al (2013) Measurement of waist circumference: midabdominal or iliac crest? Diabetes Care 36(6):1660–1666CrossRef

15.

Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D et al (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Mineral Res 11(7):984–996CrossRef

16.

Crans GG, Genant HK, Krege JH (2005) Prognostic utility of a semiquantitative spinal deformity index. Bone 37(2):175–179CrossRef

17.

Hangartner TN, Warner S, Braillon P, Jankowski L, Shepherd J (2013) The Official Positions of the International Society for Clinical Densitometry: acquisition of dual-energy X-ray absorptiometry body composition and considerations regarding analysis and repeatability of measures. J Clin Densitom 16(4):520–536CrossRef

18.

Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom 16(4):455–466CrossRef

19.

McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Mineral Res 31(5):940–948CrossRef

20.

Dittadi R, Matteucci M, Meneghetti E, Ndreu R (2018) Reassessment of the Access Testosterone chemiluminescence assay and comparison with LC-MS method. J Clin Lab Anal 32(3):e22286CrossRef

21.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930CrossRef

22.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419CrossRef

23.

Bojesen A, Birkebæk N, Kristensen K, Heickendorff L, Mosekilde L, Christiansen JS et al (2011) Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int 22(5):1441–1450CrossRef

24.

Foresta C, Ruzza G, Mioni R, Meneghello A, Baccichetti C (1983) Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res 15(1):56–57CrossRef

25.

Ferlin A, Selice R, Di Mambro A, Ghezzi M, Di Nisio A, Caretta N et al (2015) Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome. Osteoporosis Int 26(8):2193–2202CrossRef

26.

Ferlin A, Schipilliti M, Vinanzi C, Garolla A, Di Mambro A, Selice R et al (2011) Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism. J Clin Endocrinol Metab 96(4):E739–E745CrossRef

27.

Pizzocaro A, Vena W, Condorelli R, Radicioni A, Rastrelli G, Pasquali D et al (2020) Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis. J Endocrinol Invest 43(12):1675–1687CrossRef

28.

Aksglaede L, Andersson AM, Jørgensen N, Jensen TK, Carlsen E, McLachlan RI et al (2007) Primary testicular failure in Klinefelter’s syndrome: the use of bivariate luteinizing hormone-testosterone reference charts. Clin Endocrinol (Oxf) 66(2):276–281CrossRef

29.

Juel Mortensen L, Lorenzen M, Jørgensen N, Andersson AM, Nielsen JE, Petersen LI et al (2019) Possible link between FSH and RANKL release from adipocytes in men with impaired gonadal function including Klinefelter syndrome. Bone 123:103–114CrossRef

30.

Rochira V, Antonio L, Vanderschueren D (2018) EAA clinical guideline on management of bone health in the andrological outpatient clinic. Andrology 6(2):272–285CrossRef

31.

Corona G, Vena W, Pizzocaro A, Giagulli VA, Francomano D, Rastrelli G et al (2022) Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest 45(5):911–926CrossRef

32.

Ferlin A, Schipilliti M, Foresta C (2011) Bone density and risk of osteoporosis in Klinefelter syndrome. Acta paediatrica (Oslo, Norway: 1992) 100(6):878–884CrossRef

33.

Harvey NC, Glüer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C et al (2015) Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216–224CrossRef

34.

Aksglaede L, Molgaard C, Skakkebaek NE, Juul A (2008) Normal bone mineral content but unfavourable muscle/fat ratio in Klinefelter syndrome. Arch Dis Child 93(1):30–34CrossRef

35.

Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, Bennett P et al (2006) The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29(7):1591–1598CrossRef

36.

Chang S, Skakkebæk A, Trolle C, Bojesen A, Hertz JM, Cohen A et al (2015) Anthropometry in Klinefelter syndrome–multifactorial influences due to CAG length, testosterone treatment and possibly intrauterine hypogonadism. J Clin Endocrinol Metab 100(3):E508–E517CrossRef

37.

Blüher M (2009) Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117(6):241–250CrossRef

38.

Mazziotti G, Lania AG, Canalis E (2022) Skeletal disorders associated with the growth hormone–insulin- like growth factor 1 axis. Nat Rev Endocrinol 18(6):353–365CrossRef

39.

Lv S, Zhang A, Di W, Sheng Y, Cheng P, Qi H et al (2016) Assessment of Fat distribution and Bone quality with Trabecular Bone Score (TBS) in Healthy Chinese Men. Sci Rep 6:24935CrossRef

40.

Melton LJ 3rd (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Mineral Res 18(6):1139–1141CrossRef

41.

Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST et al (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221.e1–10CrossRef

42.

Bojesen A, Juul S, Birkebaek NH, Gravholt CH (2006) Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab 91(4):1254–1260CrossRef

43.

Mazziotti G, Porcelli T, Mormando M, De Menis E, Bianchi A, Mejia C et al (2011) Vertebral fractures in males with prolactinoma. Endocrine 39(3):288–293CrossRef

44.

Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A et al (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93(12):4649–4655CrossRef

45.

Mazziotti G, Bianchi A, Cimino V, Bonadonna S, Martini P, Fusco A et al (2008) Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. Pituitary 11(1):55–61CrossRef

46.

Waterloo S, Ahmed LA, Center JR, Eisman JA, Morseth B, Nguyen ND et al (2012) Prevalence of vertebral fractures in women and men in the population-based Tromsø Study. BMC Musculoskelet Disord 13:3CrossRef

47.

Cioffi CE, Alvarez JA, Welsh JA, Vos MB (2019) Truncal-to-leg fat ratio and cardiometabolic disease risk factors in US adolescents: NHANES 2003–2006. Pediatr Obes 14(7):e12509CrossRef

48.

Choi SI, Chung D, Lim JS, Lee MY, Shin JY, Chung CH et al (2017) Relationship between regional body fat distribution and diabetes mellitus: 2008 to 2010 Korean National Health and Nutrition Examination Surveys. Diabetes Metab J 41(1):51–59CrossRef

49.

Mazziotti G, Tupputi U, Ferrante G, Guglielmi G (2020) Abdominal aortic calcification as a marker of relationship between atherosclerosis and skeletal fragility. J Clin Densitom 23(4):539–542CrossRef

50.

Crepaldi G, Maggi S (2009) Epidemiologic link between osteoporosis and cardiovascular disease. J Endocrinol Invest 32(4 Suppl):2–5

51.

Hans D, Šteňová E, Lamy O (2017) The trabecular bone score (TBS) complements DXA and the FRAX as a fracture risk assessment tool in routine clinical practice. Curr Osteoporos Rep 15(6):521–531CrossRef

52.

Lindsay R, Pack S, Li Z (2005) Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis. Osteoporosis Int 16(3):306–312CrossRef

53.

Mazziotti G, Pedersini R, Vena W, Cosentini D, Carrone F, Pigni S et al (2022) Real-world effectiveness of denosumab and bisphosphonates on risk of vertebral fractures in women with breast cancer undergoing treatment with aromatase inhibitors. Calcif Tissue Int. https://doi.org/10.1007/s00223-022-01011-wCrossRef

54.

Mazziotti G, Vena W, Pedersini R, Piccini S, Morenghi E, Cosentini D et al (2022) Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice. J Bone Oncol 33:100421CrossRef

55.

Foresta C, Ferlin A, Lenzi A, Montorsi P (2017) The great opportunity of the andrological patient: cardiovascular and metabolic risk assessment and prevention. Andrology 5(3):408–413CrossRef

Titel: Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome
verfasst von: W. Vena
F. Carrone
A. Delbarba
O. Akpojiyovbi
L. C. Pezzaioli
P. Facondo
C. Cappelli
L. Leonardi
L. Balzarini
D. Farina
A. Pizzocaro
A. G. Lania
G. Mazziotti
A. Ferlin
Publikationsdatum: 01.02.2023
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 2/2023
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-022-01901-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome